Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
1986 • 6,585 citations
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
1983 • 3,942 citations
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
2001 • 644 citations
Tumoritropic and lymphotropic principles of macromolecular drugs.
1989 • 576 citations
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report
1983 • 332 citations
Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
1984 • 283 citations
A New Approach to Cancer Chemotherapy: Selective Enhancement of Tumor Blood Flow With Angiotensin II<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>
1981 • 268 citations
Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium
1984 • 230 citations
Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties
1985 • 221 citations
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
1988 • 157 citations
A LIPOPHILIC DERIVATIVE OF NEOCARZINOSTATIN A Polymer Conjugation of an Antitumor Protein Antibiotic*
1979 • 151 citations
Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer.
1988 • 127 citations
Increased Vascular Permeability in Organs Mediated by the Systemic Administration of Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 in Mice
1988 • 115 citations
Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs
1984 • 110 citations
Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study
1991 • 103 citations
Protein Binding of Macromolecular Anticancer Agent SMANCS: Characterization of Poly(styrene-co-maleic acid) Derivatives as an Albumin Binding Ligand
1988 • 59 citations
Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer.
1987 • 54 citations
Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.
1987 • 47 citations
Stimulation of Macrophage by Polyanions and Its Conjugated Proteins and Effect on Cell Membrane
1986 • 37 citations
Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
1987 • 33 citations
Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
1990 • 31 citations
Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.
1988 • 24 citations
Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin
1989 • 12 citations
Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
1989 • 10 citations